Virus Filtration Market Size, Share, Growth, Trends & Analysis 2025
Virus filtration is an effective virus clearance technology that finds its application in several biologics sectors. The global virus filtration market is expected to reach US$ 5,555.4 million by 2025 from US$ 2,139.4 million in 2017. The market is estimated to grow at a CAGR of 13.0% between 2018 and 2025.
The biopharmaceutical industry witnessed rapid growth in recent years owing to the rise in the prevalence of chronic diseases. Unlike small molecules, biological drugs are formulated using a mix of animal, plant, and synthetic sources. Some biological therapeutic products are produced using mammalian cell lines or human plasma. All of these increase the chance of contamination tenfold. The risk of contamination with viruses in these products is hazardous; hence, regulatory agencies have mandated that manufacturers evaluate the risks of virus contamination and take necessary measures to mitigate them. Virus filtration market is extensively used in the purification of biopharmaceutical products to avoid risk and follow through with the safety norms laid by regulatory bodies. Pharmaceutical companies have upped investments in virus filtration as it will play a monumental role in the safety of biopharmaceutical drug products.
In laboratories, virus easily contaminates air, water, and test samples. Therefore, the need for virus filtration is imperative. Continuous bioprocessing is rapidly gaining momentum in mAb production, providing potential advantages such as smaller facility footprints, lower investment costs, flexibility, and process economy. Continuous downstream processing relies on virus filtration during this process. The virus filtration market method uses a membrane barrier to retain virus particles to maintain a contamination-free environment. It is a strong, dependable virus clearance technology used by various end-user verticals. The global virus filtration market growth is driven by increasing biologics and biopharmaceutical products' manufacturing, stringent regulatory norms, and increasing investments in R&D and outsourcing activities.
Drivers
Rapid Growth of Pharmaceutical and Biotechnology Industry
The pharmaceutical industry has been developing tremendously in the past few years. The demand for new medicines, advanced therapies, rapid digitalization, and changing regulations pose healthcare challenges to manufacturers and contract research organizations (CROs). As per the World Health Organization (WHO), the global population is increasing by 1.24% per annum, leading to the surplus requirement for drugs and medications. The pharmaceutical industry grew 30% more than its previous estimations till 2017, retaining its position among the top five industries and adding to the global economic value. Several drug manufacturers produce affordable medicines to cater to the middle-income population in developing economies. With every new drug formulation comes the mandatory virus clearance test to assess the elimination of known or unknown viral traces.
Stringent Regulatory Framework
Key regulatory authorities such as the food & drug administration (FDA), European Medicine Agency (EMA), and others consistently track and monitor the developments in the pharmaceutical and biotechnology industry. Manufacturers abide by the updated regulations to follow current good manufacturing practices (GMP) and good laboratory practices (GLP). Any deviations from the prescribed protocols can result in the termination of the clinical trials of the concerned manufacturer or outsourced organization. The US FDA released guidelines for pharmaceutical companies regarding virus safety evaluation of the products derived from human cell lines or of animal origin. Such stringent regulations enforced by the healthcare governing bodies mandate virus clearance tests during the drug development processes.
Restraints
Availability of Alternative Techniques for Viral Clearance
The adventitious viral agents possess the inherent risk of contamination in biological drug production. The regulatory bodies have already addressed these issues in advance. The success of virus filtration depends on the preference for a suitable method. The appropriate method is a function of various biological and clinical factors. Some prominent methods include adding low pH buffer, temperature hold, and detergent treatment that inactivates virus in the biological processing solutions. Of these viable methods, virus filtration techniques are deployed only when the solutions cannot be sterilized through autoclaving. This ceases the requirement for filtration, thereby hindering the growth of the global virus filtration market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Virus Filtration Market: Strategic Insights
Market Size Value in US$ 2,139.4 Million in 2017 Market Size Value by US$ 5,555.4 Million by 2025 Growth rate CAGR of 13.0% from 2018 to 2025 Forecast Period 2018-2025 Base Year 2018
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Virus Filtration Market: Strategic Insights
| Market Size Value in | US$ 2,139.4 Million in 2017 |
| Market Size Value by | US$ 5,555.4 Million by 2025 |
| Growth rate | CAGR of 13.0% from 2018 to 2025 |
| Forecast Period | 2018-2025 |
| Base Year | 2018 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Segmentation
By Product
High Degree of Filtration in Biopharmaceutical Processes Support the Segmental Dominance
Based on product, the global virus filtration market is split into filtration systems, kits and reagents, services, and others. Among these, the kits and reagents segment occupied a notable market share in 2017. During lab-scale testing and biopharmaceutical manufacturing, kits and reagents effectively remove viruses from recombinant proteins, monoclonal antibodies, and tissue extracts. The ready-to-use commercial kits are specially used for viral DNA purification, qPCR, and immunological applications. The membranes of these kits are designed to remove viruses of specific sizes from aqueous solutions and substrates. Notably, the kits and reagents are easy and safe with little expertise and simple protocol.
The filtration systems segment was the second-largest occupant of the global virus filtration market in 2017. These filtration systems are generally used to remove parvoviruses or other specific types containing a protein coat. Filtration systems are advantageous over other virus removal techniques as they do not denature the samples' proteins. Moreover, these systems help increase the total throughput and slay down the overall virus filtration costs. As a result, they are being enormously adopted in medical device manufacturing and formulating research procedures.
By Application
Pharmaceutical Companies Conducting Several Clinical Tests Fuel the Segment’s Market Share
According to the application, the virus filtration market domain is split into biologics, medical devices, water purification, and air purification. Among these, the biologics segment led the market in 2017, with the largest revenue share. Under biological treatment therapies, a few substances are either naturally available in the body or cultivated in laboratories. These processes involve several instances leading to viral contamination. Hence, virus safety associated with plasma-derived therapeutics is assessed through virus clearance tests before submitting test results to regulatory bodies. All the pharmaceutical companies and CROs conducting the tests for clinical trials are expected to enhance the growth of the concerned segment over the coming years.
The water purification segment is anticipated to expand considerably throughout the forecast period. Enteric viruses in water can pose severe health hazards to humans and animals. They are highly resistant to the aquatic environment and cause water contamination. Filtration is a cost-effective and lucid method that produces excellent disinfection and prevents viruses from thriving in the water. It also becomes essential to purify the virus antigen from culture media that includes high volumes of water. Elimination of viral bodies from the water leads to optimum vaccination results.
Regional market
North America is the largest market for virus filtration, with the US holding the largest market share, followed by Canada. Biopharmaceutical and biotechnology companies, key market players, and various academic and research institutes have raised the demand for virus filtration systems, further stimulating the growth of North America's global virus filtration market.
Europe occupies a significant position in the global virus filtration market and is expected to register a robust growth rate owing to government and private funding for research in biologics and pharmaceuticals. Additionally, the launch of innovative technologies is likely to be the major factor driving the growth of this market in Europe. Germany is the biggest hub for biotechnology worldwide in Europe, owing to the presence of large biotech players, high-tech research labs, and massive funding for research and development.
Many developments have been witnessed in Europe and North America. This is the probable reason the market is expected to do so well in these regions during the prediction period.
Increasing research centers and government funding in Asia Pacific fuel the market's growth in the region. The government bodies provide grants to increase the participation of young researchers.
The Middle East & Africa consist of three major countries: United Arab Emirates (UAE), Saudi Arabia, and South Africa. The market in this region is driven by extensive research projects undertaken by several research institutes and the availability of infrastructure, as well as facilities for research. Government initiatives toward research and development, healthcare, and the availability of technologically advanced devices fuel the virus filtration market's growth.The South & Central America virus filtration market has grown due to recent technological developments. The low-cost advantage and higher work efficiency are the major attracting points for manufacturing companies to establish bases in South America.
Key Market Players:
- MERCK KGAA (Germany)
- Sartorius AG (Germany)
- Danaher (Pall Corporation) (US)
- Thermo Fisher Scientific Inc (US)
- General Electric (US)
- Charles River (US)
- Wuxi Apptec (China)
- Lonza (Switzerland)
- Asahi Kasei Corporation (Japan)
- Clean Cells (France)
Virus Filtration Market Report Scope
Key Developments:
- February 2018: Merck launched Viresolve Barrier capsule filters to reduce bioreactor contamination risk. These capsules remove viruses, mycoplasma, and bacteria from cell culture media.
- September 2017
:
Sartorius commenced a new facility center in Goettingen to manufacture laboratory instruments such as balances, ultrapure water systems, and moisture analyzers. - September 2016: Pall Corporation launched Pegasus Prime virus removal filters to provide retention of small viruses for critical manufacturing processes.
- April 2016:Charles River Laboratories acquired WIL Research, a premier provider of safety assessment, contract development, and manufacturing services.
Report Coverage
The global virus filtration market research report provides detailed insights into market share, size, trends, and opportunities. It briefs the role of drivers and restraints impacting market fluctuations. Besides, the industrial landscape, market overview, and global business analysis have been elaborated to help determine future business investments. With their recent developments, dominant market players have been highlighted, mentioning product launches, expansions, and acquisitions.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Application, End User and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Frequently Asked Questions
The growth of the Virus filtration in market is attributed to the rising application of Virus filtration, launch of new virus filtration system, adoption of inorganic strategies by market players and rising demand for virus filtration technologies in biotechnology and pharmaceuticals.
The services segment is anticipated to witness the fastest growth rate of 14.9% during the forecast period, 2018 to 2025.
In 2017, the kits & reagents segment held a largest market share of 54.4% of the virus filtration market, by product. This segment is also expected to dominate the market in 2025 owing to increasing demand for kits and reagents in biotechnology and pharmaceutical companies.
TABLE OF CONTENTS
1. INTRODUCTION 23
1.1 SCOPE OF THE STUDY 23
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 23
2. GLOBAL VIRUS FILTRATION MARKET – KEY TAKEAWAYS 24
3. GLOBAL VIRUS FILTRATION MARKET – MARKET LANDSCAPE 26
3.1 OVERVIEW 26
3.2 MARKET SEGMENTATION 26
3.2.1 Global Virus Filtration Market – By Product 27
3.2.2 Global Virus Filtration Market – By Application 28
3.2.3 Global Virus Filtration Market – By End User 28
3.2.4 Global Virus Filtration Market – By Geography 28
3.3 PEST ANALYSIS 29
3.3.1 North America – PEST Analysis 29
3.3.2 Europe– PEST Analysis 31
3.3.3 Asia Pacific – PEST Analysis 33
3.3.4 Middle East And Africa– PEST Analysis 35
3.3.5 South and Central America – PEST Analysis 37
4. GLOBAL VIRUS FILTRATION MARKET – KEY MARKET DYNAMICS 39
4.1 KEY MARKET DRIVERS 39
4.1.1 Rapid Growth of Pharmaceutical and Biotechnology Industry 39
4.1.2 Increasing Investments in R&D and Outsourcing Activities 40
4.1.3 Stringent Regulatory Framework 41
4.2 KEY MARKET RESTRAINTS 41
4.2.1 High Consolidation in the Market 41
4.2.2 Availability of Alternative Techniques for Viral Clearance 42
4.3 KEY MARKET OPPORTUNITIES 42
4.3.1 Growth of Pharmaceutical & Medical Device Research Outsourcing 42
4.3.2 High Market Potential In Emerging Economies 42
4.4 FUTURE TRENDS 43
4.4.1 Rapid Adoption of Single Use Technologies 43
4.5 IMPACT ANALYSIS 44
5. VIRUS FILTRATION MARKET – GLOBAL ANALYSIS 45
5.1 GLOBAL VIRUS FILTRATION MARKET REVENUE FORECASTS AND ANALYSIS 45
5.2 GLOBAL VIRUS FILTRATION MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 46
5.3 MARKET POSITIONING 47
5.4 PERFORMANCE OF KEY PLAYERS 47
5.4.1 Merck KGaA 47
5.4.2 Sartorius AG 48
5.5 EXPERT OPINIONS 48
6. VIRUS FILTRATION MARKET ANALYSIS– BY PRODUCT 49
6.1 OVERVIEW 49
6.2 KITS AND REAGENTS MARKET 50
6.2.1.1 Overview 50
6.2.1.2 Global Kits and Reagents Market Revenue and Forecasts to 2025 (US$ Mn) 50
6.3 FILTRATION SYSTEMS MARKET 51
6.3.1 Overview 51
6.3.2 Global Filtration Systems Market Revenue and Forecasts to 2025 (US$ Mn) 52
6.4 SERVICES MARKET 52
6.4.1.1 Overview 52
6.4.1.2 Global Services Market Revenue and Forecasts to 2025 (US$ Mn) 53
6.5 OTHERS MARKET 53
6.5.1.1 Overview 53
6.5.1.2 Global Others Market Revenue and Forecasts to 2025 (US$ Mn) 54
7. GLOBAL VIRUS FILTRATION MARKET ANALYSIS– BY APPLICATION 55
7.1 OVERVIEW 55
7.2 BIOLOGICS MARKET 56
7.2.1 Overview 56
7.2.2 Global Biologics Market Revenue and Forecasts to 2025 (US$ Mn) 56
7.2.3 Vaccines and Therapeutics Market 57
7.2.3.1 Overview 57
7.2.3.2 Global Vaccines and Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 57
7.2.4 Blood and Blood Products Market 58
7.2.4.1 Overview 58
7.2.4.2 Global Blood and Blood Products Market Revenue and Forecasts to 2025 (US$ Mn) 58
7.2.5 Cellular and Gene Therapy Products Market 59
7.2.5.1 Overview 59
7.2.5.2 Global Cellular and Gene Therapy Products Market Revenue and Forecasts to 2025 (US$ Mn) 59
7.2.6 Others Market 60
7.2.6.1 Overview 60
7.2.6.2 Global Others Market Revenue and Forecasts to 2025 (US$ Mn) 60
7.3 WATER PURIFICATION MARKET 61
7.3.1 Overview 61
7.3.2 Global Water Purification Market Revenue and Forecasts to 2025 (US$ Mn) 61
7.4 AIR PURIFICATION MARKET 62
7.4.1 Overview 62
7.4.2 Global Air Purification Market Revenue and Forecasts to 2025 (US$ Mn) 62
8. GLOBAL VIRUS FILTRATION MARKET ANALYSIS– BY END USER 63
8.1 OVERVIEW 63
8.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET 64
8.2.1 Overview 64
8.2.2 Global Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2025 (US$ Mn) 64
8.3 CONTRACT RESEARCH ORGANIZATIONS MARKET 65
8.3.1 Overview 65
8.3.2 Global Contract Research Organizations Market Revenue and Forecasts to 2025 (US$ Mn) 66
8.4 MEDICAL DEVICE COMPANIES MARKET 67
8.4.1 Overview 67
8.4.2 Global Medical Device Companies Market Revenue and Forecasts to 2025 (US$ Mn) 67
8.5 ACADEMIC & RESEARCH INSTITUTES MARKET 68
8.5.1 Overview 68
8.5.2 Global Academic & Research Institutes Market Revenue and Forecasts to 2025 (US$ Mn) 68
9. NORTH AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 69
9.1 OVERVIEW 69
9.2 NORTH AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
9.3 NORTH AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 70
9.4 NORTH AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 71
9.4.1 North America Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 71
9.5 NORTH AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 72
9.6 NORTH AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 72
9.7 US VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
9.7.1 US Virus Filtration Market Revenue and Forecasts to 2025 (US$ Mn) 73
9.7.2 US Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 74
9.7.3 US Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 74
9.7.3.1 US Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 74
9.7.4 US Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 75
9.8 CANADA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 76
9.8.1 Canada Virus Filtration Market Revenue and Forecasts to 2025 (US$ Mn) 77
9.8.2 Canada Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 77
9.8.3 Canada Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 78
9.8.3.1 Canada Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 78
9.8.4 Canada Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 78
9.9 MEXICO VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 79
9.9.1 Mexico Virus filtration Market Revenue and Forecasts to 2025 (US$ Mn) 79
9.9.2 Mexico Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 80
9.9.3 Mexico Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 80
9.9.3.1 Mexico Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 80
9.9.4 Mexico Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 81
10. EUROPE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 82
10.1 OVERVIEW 82
10.2 EUROPE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83
10.3 EUROPE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 83
10.4 EUROPE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 84
10.4.1 Europe Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 84
10.5 EUROPE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 84
10.6 EUROPE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 85
10.7 GERMANY VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 86
10.7.1 Germany Virus Filtration Market Revenue and Forecasts to 2025 (US$ Mn) 86
10.7.2 Germany Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 87
10.7.3 Germany Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 87
10.7.3.1 Germany Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 87
10.7.4 Germany Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 88
10.8 UK VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 89
10.8.1 UK Virus Filtration Market Revenue and Forecasts to 2025 (US$ Mn) 89
10.8.2 UK Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 90
10.8.3 UK Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 90
10.8.3.1 UK Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 90
10.8.4 UK Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 91
10.9 FRANCE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 92
10.9.1 France Virus Filtration Market Revenue and Forecasts to 2025 (US$ Mn) 92
10.9.2 France Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 93
10.9.3 France Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 93
10.9.3.1 France Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 93
10.9.4 France Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 94
11. ASIA PACIFIC VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 95
11.1 OVERVIEW 95
11.2 ASIA PACIFIC VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 96
11.3 ASIA PACIFIC VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 96
11.4 ASIA PACIFIC VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 97
11.4.1 Asia Pacific Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 97
11.5 ASIA PACIFIC VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 97
11.6 ASIA PACIFIC VIRUS FILTRATION MARKET SHARE BY COUNTRY, 2017 AND 2025 (%) 98
11.7 CHINA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99
11.7.1 China Virus Filtration Market Revenue and Forecasts to 2025 (US$ Mn) 99
11.7.2 China Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 100
11.7.3 China Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 100
11.7.3.1 China Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 100
11.7.4 China Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 101
11.8 JAPAN VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 102
11.8.1 Japan Virus Filtration Market Revenue and Forecasts to 2025 (US$ Mn) 102
11.8.2 Japan Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 103
11.8.3 Japan Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 103
11.8.3.1 Japan Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 103
11.8.4 Japan Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 104
11.9 INDIA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 105
11.9.1 India Virus Filtration Market Revenue and Forecasts to 2025 (US$ Mn) 106
11.9.2 India Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 106
11.9.3 India Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 107
11.9.3.1 India Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 107
11.9.4 India Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 107
12. MIDDLE EAST AND AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 108
12.1 OVERVIEW 108
12.2 MIDDLE EAST AND AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 109
12.3 MIDDLE EAST AND AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 109
12.4 MIDDLE EAST AND AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 110
12.4.1 Middle East and Africa Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 110
12.5 MIDDLE EAST AND AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 111
12.6 MIDDLE EAST AND AFRICA VIRUS FILTRATION MARKET SHARE BY COUNTRY, 2017 AND 2025 (%) 111
12.7 UAE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 112
12.8 UAE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 112
12.8.1 UAE Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 113
12.8.2 UAE Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 113
12.8.2.1 UAE Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 113
12.8.3 UAE Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 114
12.9 SAUDI ARABIA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 115
12.10 SAUDI ARABIA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 115
12.10.1 Saudi Arabia Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 116
12.10.2 Saudi Arabia Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 116
12.10.2.1 Saudi Arabia Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 116
12.10.3 Saudi Arabia Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 117
12.11 SOUTH AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 118
12.12 SOUTH AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 118
12.12.1 South Africa Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 119
12.12.2 South Africa Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 119
12.12.2.1 South Africa Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 119
12.12.3 South Africa Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 120
13. SOUTH AND CENTRAL AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 121
13.1 OVERVIEW 121
13.2 SOUTH AND CENTRAL AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 122
13.3 SOUTH AND CENTRAL AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 122
13.4 SOUTH AND CENTRAL AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 123
13.4.1 South and Central America Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 123
13.5 SOUTH AND CENTRAL AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 124
13.6 SOUTH AND CENTRAL AMERICA VIRUS FILTRATION MARKET SHARE BY COUNTRY, 2017 AND 2025 (%) 124
13.7 BRAZIL VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 125
13.7.1 Brazil Virus Filtration Market Revenue and Forecasts to 2025 (US$ Mn) 125
13.7.2 Brazil Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 126
13.7.3 Brazil Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 126
13.7.3.1 Brazil Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 126
13.7.4 Brazil Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 127
14. VIRUS FILTRATION MARKET –INDUSTRY LANDSCAPE 128
14.1 OVERVIEW 128
14.2 GROWTH STRATEGIES IN THE VIRUS FILTRATION MARKET, 2015-2018 128
14.3 ORGANIC DEVELOPMENTS 128
14.3.1 Overview 128
14.4 ORGANIC GROWTH STRATEGIES IN THE VIRUS FILTRATION MARKET, 2015-2018 129
14.5 PRODUCT LAUNCH 129
14.5.1 Recent Product Launches By Players In The Virus filtration Market 129
14.6 EXPANSION 130
14.6.1 Expansion In The Virus Filtration Market 130
14.7 INORGANIC DEVELOPMENTS 131
14.7.1 Overview 131
14.8 INORGANIC GROWTH STRATEGIES IN THE VIRUS FILTRATION MARKET, 2015-2018 131
14.9 ACQUISITION 131
14.9.1 Recent Acquisitions by Players in the Virus filtration Market 131
14.10 OTHERS 132
14.10.1 Other Organic Developments In The Virus filtration Market 132
15. VIRUS FILTRATION MARKET –KEY COMPANY PROFILES 133
15.1 MERCK KGAA 133
15.1.1 Key Facts 133
15.1.2 Business Description 133
15.1.3 Financial Overview 134
15.1.4 Product Portfolio 134
15.1.5 SWOT Analysis 135
15.1.6 Key Developments 135
15.2 SARTORIUS AG 136
15.2.1 Key Facts 136
15.2.2 Business Description 136
15.2.3 Financial Overview 137
15.2.4 Product Portfolio 137
15.2.5 SWOT Analysis 138
15.2.6 Key Developments 138
15.3 DANAHER (PALL CORPORATION) 140
15.3.1 Key Facts 140
15.3.2 Business Description 140
15.3.3 Financial Overview 141
15.3.4 Product Portfolio 141
15.3.5 SWOT Analysis 142
15.3.6 Key Developments 142
15.4 THERMO FISHER SCIENTIFIC INC. 143
15.4.1 Key Facts 143
15.4.2 Business Description 143
15.4.3 Financial Overview 144
15.4.4 Product Portfolio 144
15.4.5 SWOT Analysis 145
15.4.6 Key Developments 145
15.5 GENERAL ELECTRIC 146
15.5.1 Key Facts 146
15.5.2 Business Description 146
15.5.3 Financial Overview 147
15.5.4 Product portfolio 147
15.5.5 SWOT Analysis 149
15.5.6 KEY DEVELOPMENTS 149
15.6 CHARLES RIVER 150
15.6.1 Key Facts 150
15.6.2 Business Description 150
15.6.3 Financial Overview 151
15.6.4 Service Portfolio 151
15.6.5 Swot Analysis 151
15.6.6 Key Developments 152
15.7 WUXI APPTEC 153
15.7.1 Key Facts 153
15.7.2 Business Description 153
15.7.3 Financial Overview 153
15.7.4 Product Portfolio 153
15.7.5 SWOT Analysis 154
15.7.6 Key Developments 154
15.8 LONZA 155
15.8.1 Key Facts 155
15.8.2 Business Description 155
15.8.3 Financial Overview 156
15.8.4 Product/Service Portfolio 156
15.8.5 SWOT Analysis 156
15.8.6 Key Developments 157
15.9 ASAHI KASEI CORPORATION 158
15.9.1 Key Facts 158
15.9.2 Business Description 158
15.9.3 Financial Overview 159
15.9.4 Product Portfolio 159
15.9.5 SWOT Analysis 160
15.9.6 Key Developments 160
15.10 CLEAN CELLS 161
15.10.1 Key Facts 161
15.10.2 Business Description 161
15.10.3 Financial Overview 161
15.10.4 Product Portfolio 161
15.10.5 SWOT Analysis 162
15.10.6 Key Developments 162
16. APPENDIX 163
16.1 ABOUT THE INSIGHT PARTNERS 163
16.2 GLOSSARY OF TERMS 164
16.3 METHODOLOGY 166
16.3.1 Coverage 167
16.3.2 Secondary Research 168
16.3.3 Primary Research 168
LIST OF TABLES
TABLE 1. R&D INVESTMENTS BY MAJOR PHARMACEUTICAL COMPANIES 40
TABLE 2. R&D INVESTMENTS BY PHRMA MEMBER COMPANIES,2016 40
TABLE 3. NORTH AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 70
TABLE 4. NORTH AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 71
TABLE 5. NORTH AMERICA BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 71
TABLE 6. NORTH AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 72
TABLE 7. US VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 74
TABLE 8. US VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 74
TABLE 9. US BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 74
TABLE 10. US VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 75
TABLE 11. CANADA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 77
TABLE 12. CANADA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 78
TABLE 13. CANADA BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 78
TABLE 14. CANADA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 78
TABLE 15. MEXICO VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 80
TABLE 16. MEXICO VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 80
TABLE 17. MEXICO BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 80
TABLE 18. MEXICO VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 81
TABLE 19. EUROPE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 83
TABLE 20. EUROPE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 84
TABLE 21. EUROPE BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 84
TABLE 22. EUROPE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 84
TABLE 23. GERMANY VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 87
TABLE 24. GERMANY VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 87
TABLE 25. GERMANY BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 87
TABLE 26. GERMANY VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 88
TABLE 27. UK VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 90
TABLE 28. UK VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 90
TABLE 29. UK BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 90
TABLE 30. UK VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 91
TABLE 31. FRANCE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 93
TABLE 32. FRANCE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 93
TABLE 33. FRANCE BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 93
TABLE 34. FRANCE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 94
TABLE 35. ASIA PACIFIC VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 96
TABLE 36. ASIA PACIFIC VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 97
TABLE 37. ASIA PACIFIC BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 97
TABLE 38. ASIA PACIFIC VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 97
TABLE 39. CHINA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 100
TABLE 40. CHINA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 100
TABLE 41. CHINA BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 100
TABLE 42. CHINA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 101
TABLE 43. JAPAN VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 103
TABLE 44. JAPAN VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 103
TABLE 45. JAPAN BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 103
TABLE 46. JAPAN VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 104
TABLE 47. INDIA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 106
TABLE 48. INDIA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 107
TABLE 49. INDIA BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 107
TABLE 50. INDIA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 107
TABLE 51. MIDDLE EAST AND AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 109
TABLE 52. MIDDLE EAST AND AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 110
TABLE 53. MIDDLE EAST AND AFRICA BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 110
TABLE 54. MIDDLE EAST AND AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 111
TABLE 55. MIDDLE EAST AND AFRICA VIRUS FILTRATION MARKET SHARE BY COUNTRY, 2017 AND 2025 (%) 111
TABLE 56. UAE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 113
TABLE 57. UAE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 113
TABLE 58. UAE BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 113
TABLE 59. UAE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 114
TABLE 60. SAUDI ARABIA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 116
TABLE 61. SAUDI ARABIA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 116
TABLE 62. SAUDI ARABIA BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 116
TABLE 63. SAUDI ARABIA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 117
TABLE 64. SOUTH AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 119
TABLE 65. SOUTH AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 119
TABLE 66. SOUTH AFRICA BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 119
TABLE 67. SOUTH AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 120
TABLE 68. SOUTH AND CENTRAL AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 122
TABLE 69. SOUTH AND CENTRAL AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 123
TABLE 70. SOUTH AND CENTRAL AMERICA BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 123
TABLE 71. SOUTH AND CENTRAL AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 124
TABLE 72. BRAZIL VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 126
TABLE 73. BRAZIL VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 126
TABLE 74. BRAZIL BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 126
TABLE 75. BRAZIL VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 127
TABLE 76. RECENT PRODUCT LAUNCHES IN THE VIRUS FILTRATION MARKET 129
TABLE 77. EXPANSION IN THE VIRUS FILTRATION MARKET 130
TABLE 78. RECENT ACQUISITIONS IN THE VIRUS FILTRATION MARKET 131
TABLE 79. OTHER ORGANIC DEVELOPMENTS IN THE VIRUS FILTRATION MARKET 132
TABLE 80. GLOSSARY OF TERMS, VIRUS FILTRATION MARKET 164
LIST OF FIGURES
FIGURE 1. ASIA PACIFIC VIRUS FILTRATION MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2025 24
FIGURE 2. GLOBAL VIRUS FILTRATION MARKET BY PRODUCT, MARKET SHARE (%), 2017 24
FIGURE 3. GLOBAL VIRUS FILTRATION MARKET BY APPLICATION, MARKET SHARE (%), 2017 25
FIGURE 4. GLOBAL VIRUS FILTRATION MARKET BY END USER, MARKET SHARE (%), 2017 25
FIGURE 5. VIRUS FILTRATION MARKET SEGMENTATION 26
FIGURE 6. VIRUS FILTRATION SEGMENTATION, BY REGION 27
FIGURE 7. NORTH AMERICA PEST ANALYSIS 29
FIGURE 8. EUROPE PEST ANALYSIS 31
FIGURE 9. ASIA PACIFIC PEST ANALYSIS 33
FIGURE 10. MIDDLE EAST AND AFRICA PEST ANALYSIS 35
FIGURE 11. SOUTH AND CENTRAL AMERICA PEST ANALYSIS 37
FIGURE 12. VIRUS FILTRATION MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 44
FIGURE 13. GLOBAL VIRUS FILTRATION MARKET – REVENUE FORECASTS AND ANALYSIS – 2016- 2025 45
FIGURE 14. GLOBAL VIRUS FILTRATION MARKET – BY GEOGRAPHY FORECASTS AND ANALYSIS – 2017- 2025 46
FIGURE 15. GLOBAL VIRUS FILTARTION MARKET – KEY MARKET PLAYERS 47
FIGURE 16. GLOBAL VIRUS FILTRATION MARKET BREAKDOWN, BY PRODUCT 2017 & 2025 (%) 49
FIGURE 17. GLOBAL KITS AND REAGENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 50
FIGURE 18. GLOBAL FILTRATION SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 52
FIGURE 19. GLOBAL SERVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 53
FIGURE 20. GLOBAL OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
FIGURE 21. GLOBAL VIRUS FILTRATION MARKET SHARE, BY APPLICATION 2017 & 2025 (%) 55
FIGURE 22. GLOBAL BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 56
FIGURE 23. GLOBAL VACCINES AND THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 57
FIGURE 24. GLOBAL BLOOD AND BLOOD PRODUCTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58
FIGURE 25. GLOBAL CELLULAR AND GENE THERAPY PRODUCTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 59
FIGURE 26. GLOBAL OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 60
FIGURE 27. GLOBAL WATER PURIFICATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
FIGURE 28. GLOBAL AIR PURIFICATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 62
FIGURE 29. GLOBAL VIRUS FILTRATION MARKET SHARE, BY END USER 2017 & 2025 (%) 63
FIGURE 30. GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64
FIGURE 31. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 66
FIGURE 32. GLOBAL MEDICAL DEVICE COMPANIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67
FIGURE 33. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 68
FIGURE 34. NORTH AMERICA VIRUS FILTRATION MARKET OVERVIEW, BY COUNTRY (2017) 69
FIGURE 35. NORTH AMERICA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
FIGURE 36. NORTH AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 72
FIGURE 37. US VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
FIGURE 38. CANADA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 77
FIGURE 39. MEXICO VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 79
FIGURE 40. EUROPE VIRUS FILTRATION MARKET OVERVIEW, BY COUNTRY (2017) 82
FIGURE 41. EUROPE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83
FIGURE 42. EUROPE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 85
FIGURE 43. GERMANY VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 86
FIGURE 44. UK VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 89
FIGURE 45. FRANCE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 92
FIGURE 46. ASIA PACIFIC VIRUS FILTRATION MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 95
FIGURE 47. ASIA PACIFIC VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 96
FIGURE 48. ASIA PACIFIC VIRUS FILTRATION MARKET SHARE BY COUNTRY, 2017 AND 2025 (%) 98
FIGURE 49. CHINA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99
FIGURE 50. JAPAN VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 102
FIGURE 51. INDIA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 106
FIGURE 52. MIDDLE EAST AND AFRICA VIRUS FILTRATION MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 108
FIGURE 53. MIDDLE EAST AND AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 109
FIGURE 54. UAE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 112
FIGURE 55. SAUDI ARABIA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 115
FIGURE 56. SOUTH AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 118
FIGURE 57. SOUTH AND CENTRAL AMERICA VIRUS FILTRATION MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 121
FIGURE 58. SOUTH AND CENTRAL AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 122
FIGURE 59. SOUTH AND CENTRAL AMERICA VIRUS FILTRATION MARKET SHARE BY COUNTRY, 2017 AND 2025 (%) 124
FIGURE 60. BRAZIL VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 125
FIGURE 61. GROWTH STRATEGIES IN THE VIRUS FILTRATION MARKET, 2015-2018 128
FIGURE 62. ORGANIC GROWTH STRATEGIES IN THE VIRUS FILTRATION MARKET, 2015-2018 129
FIGURE 63. INORGANIC DEVELOPMENTS IN THE VIRUS FILTRATION MARKET, 2015-2018 131
The List of Companies
1. Merck KGaA
2. Sartorius AG
3. Danaher (Pall Corporation)
4. Thermo Fisher Scientific, Inc.
5. General Electric
6. Charles River
7. Wuxi Apptec
8. Lonza
9. Asahi Kesai Corporation
10. Clean Cells
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For